Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bupivacaine 0.125% vs 0.25% in SCPB for Tympanomastoid Surgery
NCT06381401Phase 4Recruiting
- Sponsor
- Cairo University
- Start
- May 2024
- Primary completion
- Jun 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of bupivacaine in acute postoperative pain, sponsored by Cairo University. Started May 2024; status: recruiting.
02
Drugs
bupivacaine
03
Conditions
acute postoperative pain
Beyond the preview
Go deeper on NCT06381401.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06381401.